Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak

Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525. doi: 10.1016/S2468-1253(20)30085-6. Epub 2020 Mar 25.

Authors

Fabiana Zingone¹, Edoardo Vincenzo Savarino²

Affiliations

¹ Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35121 Padua, Italy. Electronic address: fabiana.zingone@unipd.it.
² Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35121 Padua, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
Biological Products*
COVID-19
Coronavirus Infections
Humans
Inflammatory Bowel Diseases*
Pandemics
Pneumonia, Viral
SARS-CoV-2

Substances

Biological Products